OncoLink Cancer Treatment and Resources

Laparoscopic Radical Prostatectomy: Preliminary Results

C. C. Abbou, L. Salomon, A. Hoznek, et al.
Abramson Cancer Center of the University of Pennsylvania
Last Modified: November 1, 2001

Reviewers: Li Liu, MD
Source: Urology, Volume 55:630-634, (May) 2000.

Précis: Laparoscopy permits more precise dissection during radical prostatectomy

Introduction

The standard surgical procedure for patients with organ confined prostate cancer has been retropubic radical prostatectomy. Minimally invasive surgical techniques have received a great deal of recent attention because of the potential for decreased postoperative discomfort, minimal disfigurement, and quicker recovery than traditional techniques. As a minimally invasive technique, laparoscopy has been used to treat many urologic disease entities and has demonstrated both clinical and economic advantages in several settings. This report is of a preliminary evaluation of the technique for radical prostatectomy.

Method

In this study, a total of 43 men with early stage prostate cancer underwent laparoscopic radical prostatectomy with or without lymphadenectomy.

Results

  • Median operating time after the first 10 patients was 4.3 hours in 21 patients without lymphadenectomy and 5.1 hours in 12 patients with lymphadenectomy.
  • None of the patients required conversion to open surgery.
  • At one month after surgery, serum prostate-specific antigen (PSA) levels were less than 0.1 ng/mL in all patients.
  • Thirty-six patients (84%) were fully continent one month after surgery, and the remaining seven reported only minor incontinence.

Discussion

Very early results suggest that laparoscopic radical prostatectomy may be as effective a treatment for early stage prostate cancer as open surgery. The goals of surgery for patient with prostate cancer are many, but foremost is the need to cure. If the two surgical approaches offer equivalent long-term surgical outcome, then it will be necessary to compare perioperative outcomes, including length of stay, convalescence, and cosmetic result.

OncoLink I wish u knew...

Dr. O'Dwyer discusses pancreatic cancer, family history, screening and future research. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS